Showing results (71-80 of 188) with videos related to
Sort By:
Pageof 19
Sexually Transmitted Diseases|May 4, 1999
Usefulness of partner notification for syphilis controlK S Kohl, T A Farley, J Ewell, et al.The Journal of Infectious Diseases|November 1, 1980
Polymorphonuclear leukocytes of human colostrum. I. Oxidative metabolism and kinetics of killing of radiolabeled Staphylococcus aureusL K Pickering, T G Cleary, S Kohl, et al.Cancer|October 1, 1980
Effect of antineoplastic drugs on human leukocyte-mediated cytotoxicity against herpes simplex virus infected cellsR Bolivar, S Kohl, L K Pickering, et al.Emerging Infectious Diseases|June 20, 2012
Assessment of public health events through International Health Regulations, United States, 2007-2011Katrin S Kohl, Ray R Arthur, Ralph O'Connor, et al.Infection and Immunity|October 1, 1984
Cytotoxicity of human peripheral blood and colostral leukocytes against Shigella speciesD R Morgan, H L DuPont, B Gonik, et al.Epidemiology and Infection|October 31, 2002
Relationship between home food-handling practices and sporadic salmonellosis in adults in Louisiana, United StatesK S Kohl, K Rietberg, S Wilson, et al.The Journal of Infectious Diseases|February 1, 1989
Interleukin-2 protects neonatal mice from lethal herpes simplex virus infection: a macrophage-mediated, gamma interferon-induced mechanismS Kohl, L S Loo, D B Drath, et al.The Journal of Clinical Investigation|July 1, 1990
Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein BS Kohl, N C Strynadka, R S Hodges, et al.The Journal of Infectious Diseases|October 1, 1993
Antibodies to epitopes of herpes simplex virus type 1 glycoprotein B (gB) in human sera: analysis of functional gB epitopes defined by inhibition of murine monoclonal antibodiesL Sanchez-Pescador, L Pereira, E D Charlebois, et al.The Journal of Infectious Diseases|November 1, 1996
Interleukin-12 administered in vivo decreases human NK cell cytotoxicity and antibody-dependent cellular cytotoxicity to human immunodeficiency virus-infected cellsS Kohl, M Sigaroudinia, E D Charlebois, et al.Pageof 19